Home → E-shop → Antiviral compounds → (-)-Carbovir – CAS 120443-30-3

(-)-Carbovir – CAS 120443-30-3

(-)-Carbovir – CAS 120443-30-3 is synthesised by Sigut Labs (Prague, Czech Republic).

Purity (LC-MS)

97%+

Package contents

(-)-Carbovir

This compound is for research use only. We do not sell to patients.

Amount

250 mg		€ 700	Stock
Do you want custom amount?				Custom amount

Amount

250 mg

€ 700

Stock

Do you want custom amount?

Custom amount

Characterisation

CAS: 120443-30-3

IUPAC name: 2-amino-9-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-1H-purin-6-one

Other names: (-)-CBV

Molecular weight: 247.25 g/mol

Molecular formula: C₁₁H₁₃N₅O₂

InChI: InChI=1S/C11H13N5O2/c12-11-14-9-8(10(18)15-11)13-5-16(9)7-2-1-6(3-7)4-17/h1-2,5-7,17H,3-4H2,(H3,12,14,15,18)/t6-,7+/m1/s1

Description

(-)-Carbovir is a nucleoside reverse transcriptase inhibitor homolog of guanosine. (-)-Carbovir reduces HIV viral levels, slows or avoids immune system damage, and lowers the chance of acquiring AIDS.

Chemicals are distributed worldwide

Buy (-)-Carbovir now, and get your order in 48 hours

Shipping through DHL in 48 hours
Sensitive compounds are shipped on dry ice
All compounds are safely and rigorously packed

Payment

Payment terms 30 days net
We are sending the invoice the same day as the shipment
We are able to modify the invoice for the academic institution, so the order can be paid from grants

References

Hawkins, T., Veikley, W., Claire III, R. L. S., Guyer, B., Clark, N., & Kearney, B. P. (2005). Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes, 39(4), 406-411.
White, E. L., Parker, W. B., Macy, L. J., Shaddix, S. C., McCaleb, G., Secrist III, J. A., … & Shannon, W. M. (1989). Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases. Biochemical and biophysical research communications, 161(2), 393-398.